Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy

International Journal of Cardiovascular Interventions

Volumn 7, Issue 3, 2005, Pages 134-137

  Pedone, Chiara ^b   Vijayakumar, Maniyal ^a   Ligthart, Jourgen M L ^a   Valgimigli, Marco ^a   Biagini, Elena ^a   De Jong, Nico ^a   Serruys, Patrick W ^a   Ten Cate, Folkert J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

Contrast agent; Hypertrophic obstructive cardiomyopathy; Intracardiac echocardiography; Percutaneous transluminal myocardial septal ablation

Indexed keywords

ALCOHOL; CONTRAST MEDIUM;

ADULT; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE INTENSIFIER; IMAGE QUALITY; MALE; PRIORITY JOURNAL; SIGNAL DETECTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND TRANSDUCER;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY; FEMALE; HEART BLOCK; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 27144451455     PISSN: 14628848     EISSN: 14711796     Source Type: Journal    
DOI: 10.1080/14628840500280575     Document Type: Article

References (20)

1. Schulte HD, Borisov K, Gams E, Gramsch-Zabel H, Losse B, Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy-long term results after surgical theraphy. Thorac Cardiovasc Surg. 1999;47:213-28.
2. Merrill WH, Friesinger GC, Graham TP Jr, et al. Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 2000; 69:1732-35.
3. van der Lee C, Kofflard MJ, van Herwerden LA, Vletter WB, ten Cate FJ. Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation. 2003;108: 2088-2092.
4. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997; 29:435-41.
5. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, cross-over study (M-PATHY). Circulation. 1999;99:2927-33.
6. Kappemberg LJ, Linde C, Jeanrenaud X, et al. Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy (PIC) Study Group. Europace. 1999; 1:77-84.
7. Faber L, Meissner A, Ziemssen P, Seggewiss H. Percutaneuos transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Long term follow up of the first series of 25 patients. Heart. 2000;83:326-31.
8. Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH III. Non surgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. One-year follow-up. J Am Coll Cardiol. 2000;36:852-55.
9. Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998; 17:1750-55.
10. Nagueh SF, Lakkis NM, He ZX, et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998;32:225-29.
11. Faber L, Seggewiss H, Gleichmann U. Percutaneuos transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intra-procedural myocardial contrast echocardiography. Circulation. 1998;98:2415-21.
12. Faber L, Ziemssen P, Seggewiss H. Targeting percutaneuos transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. J Am Soc Echocardiogr. 2000;13:1074-79.
13. Reinhard W, ten Cate FJ, Scholten M, De Laat LE, Vos J. Permanent pacing for complete atrioventricular block after nonsurgical (alchool) septal reduction in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2004;93: 1064-66.
14. Flores-Ramirez R, Lakkis NM, Middleton KJ, Killip D, Spencer WH 3rd, Nagueh SF. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001;37:208-14.
15. Henein MY, O'Sullivan CA, Ramzy IS, Sigwart U, Gibson DG. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999; 34:1117-22.
16. Chang SM, Nagueh SF, Spencer WH 3rd, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003;42:296-300.
17. Mullen MJ, Dias BF, Walker F, Siu SC, Benson LN, McLaughlin PR. Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol. 2003;41:285-92.
18. Bertel T, Konorza T, Arjumand J, et al. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation. 2003;18:795-97.
19. Szili-Torok T, Kimman GP, Theuns D, Res J, Roelandt JR, Jordaens LJ. Visualization of intra-cardiac structures and radiofrequency lesions using intracardiac echocardiography. Eur J Echoacardiogr. 2003;4:17-22.
20. Marrouche NF, Martin DO, Wazni O, et al. A. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation. 2003;197:2710-16.